Noah Johnson, PhD

Assistant Research Professor, Neurology


FacultyPhoto
Graduate School
  • PhD, University of Pittsburgh (2014)
Fellowships
  • University of California San Francisco - Memory and Aging Center, Neuroscience (2018)
Languages
English
Department
Neurology

Professional Titles

  • Research Assistant Professor

Publications

  • Coughlan C, Lindenberger J, Jacot JG, Johnson NR, Anton P, Bevers S, Welty R, Graner MW, Potter H. Specific Binding of Alzheimer's Aß Peptides to Extracellular Vesicles. Int J Mol Sci. 2024 Mar 26;25(7). PubMed PMID: 38612514
  • James E, Vielle A, Cusato K, Li H, Lee B, Parween S, Howell A, Johnson NR, Chial HJ, Potter H, Vergara MN. Human iPSC-derived retinal organoids develop robust Alzheimer's disease neuropathology. Front Cell Neurosci. 2024;18:1340448. PubMed PMID: 38323188
  • Johnson NR, Yuan P, Castillo E, Lopez TP, Yue W, Bond A, Rivera BM, Sullivan MC, Hirouchi M, Giles K, Aoyagi A, Condello C. CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tauopathy mouse model. Nat Commun. 2023 Jan 9;14(1):118. PubMed PMID: 36624100
  • Johnson NR, Wang AC, Coughlan C, Sillau S, Lucero E, Viltz L, Markham N, Allen C, Dhanasekaran AR, Chial HJ, Potter H. Imipramine and olanzapine block apoE4-catalyzed polymerization of Aß and show evidence of improving Alzheimer's disease cognition. Alzheimers Res Ther. 2022 Jun 29;14(1):88. PubMed PMID: 35768831
  • Johnson NR, Wang ACJ, Coughlan C, Sillau S, Lucero E, Viltz L, Markham N, Allen C, Dhanasekaran AR, Chial HJ, Potter H. Imipramine and olanzapine block apoE4-catalyzed polymerization of Aß and show evidence of improving Alzheimer’s disease cognition. Alz Res Ther. 2022, 14(1):88. PMID: 35768831.

Practice Locations

UCHealth Neurosciences Center - Anschutz Medical Campus
1635 Aurora Ct
4th Floor
Aurora, CO 80045
720-848-2080

Center Affiliations